Sleeping tablets or other sleep aids are routinely used to treat insomnia and occasional sleepiness. The sedative impact of a sleep aid varies depending on its chemical composition. The rising incidence of sleeping disorders such as insomnia and sleep apnea is likely to drive development in the worldwide Sleep Aids Market during the forecast period. Key firms working on product clearance for treatment of insomnia, a kind of sleep problem, are projected to drive growth in the worldwide Sleep Aids Market. The primary factors impeding the growth of the worldwide Sleep Aids Market, contain sleeping pill adverse effects, which will impede the worldwide Sleep Aids Market.
According to Coherent Market Insights, Global Sleep Aids Market is estimated to be valued at US$ 68,360.2 million in 2022 and is expected to exhibit a CAGR of 7.3% during the forecast period (2022-2030).
Prominent Players in the Sleep Aids Industry:
1. Sanofi
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. Sanofi was founded in 1973 and is headquartered in Paris, France. In July 2021, first oral medication for both stages of the Trypanosoma brucie gambiense variant of sleeping sickness, Fexinidazole from Sanofi.
2. Merck & Co. Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. On November 2022, Merck to Acquire Imago BioSciences, Inc. Acquisition expands Merck’s growing hematology portfolio
3. Pfizer Inc.
Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sell biopharmaceutical products worldwide.
4. Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. Koninklijke Philips proclaimed the introduction of Dream Station Go in April 2017 and its latest and lowest optimistic airway pressure (PAP) apparatus intended to shorten portable for patients existing with OSA.
5. GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV. Founded in 2000, headquartered in England, U.K. GSK announced the agreement signing to influence hereditary understandings for the expansion of innovative medicines in Jul 2018.
6. AstraZeneca
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development,zmanufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153.
7. Eisai Co., Ltd.
Eisai is a human healthcare company that provides products and services to its patients and their families under any healthcare system. The company was founded in 1941, headquartered in Tokyo Japan.Eisai Co., Ltd. broadcasted that the USFDA permitted a new drug tender for its internal revealed and advanced orexin antagonist binding receptor DAYVIGOTM (Lemborexant) in Dec 2019. Lemborexant or DAYVIGOTM was accepted for the treating characteristics of insomnia by problems with sleep problems in adults.
8. Tris Pharma, Inc.
Tris Pharma, Inc. is focuses on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. The company was founded 2000, headquartered in New Jersey, U.S.
9. Novartis AG
The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. In January 2020, Novartis AG announced that it had completed acquisition of The Medicines Company, a pharmaceutical company.
*Definiton- Sleep aids are medications and medical equipment used to diagnose and treat sleep problems. Medication, sleep labs, sleep apnea devices, and mattresses and pillows are all examples of sleep aids.
